Aura Biosciences
AURA
AURA
64 hedge funds and large institutions have $254M invested in Aura Biosciences in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.35% more ownership
Funds ownership: 71.6% → 71.95% (+0.35%)
24% less capital invested
Capital invested by funds: $334M → $254M (-$80.1M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Holders
64
Holding in Top 10
3
Calls
–
Puts
$9K
Top Buyers
| 1 | +$13.6M | |
| 2 | +$1.48M | |
| 3 | +$802K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$642K |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$484K |
Top Sellers
| 1 | -$5.21M | |
| 2 | -$2.66M | |
| 3 | -$534K | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$533K |
| 5 |
Citigroup
New York
|
-$377K |